Orchid Chemicals & Pharmaceuticals Ltd.
Audited Financial Results for the year ended March 31, 2008
S.No
Particulars
Three months ended
31-March-08 (Unaudited)
Three Months ended
31-Mar-07
(Unaudited)
Year ended
31-March-08
(Audited)
Year ended
31-March-07
(Audited)
Consolidated year ended 31-Mar-08
(Audited)
Consolidated year ended 31-Mar-07
(Audited)
1
 Sales and Operating Income
37,919.36
24,320.39
123,891.62

91,291.78
130,096.39
96,382.30
2
 Other Income
33.46
29.42
124.20
155.98
3.70
35.62
3
Total Income (1+2)
37,952.82
24,349.81
124,015.82
91,447.76
130,100.09
96,417.92
4
 Expenditure            

a) Decrease/(Increase) in Stock in trade
5,879.29
(1,149.34)
(1,933.77)
(14,012.10)
(2,530.48)
(13,745.93)
b) Material Cost
11,611.78
8,469.27
42,829.35
42,899.90
47,892.96
46,750.94
c) Purchase of Trades Goods
211.73
610.30
2,569.32
2,167.75
2,569.33
2,358.70
 
d) Staff Cost
2,550.19
2,038.34
9,989.76
7,772.57
11,714.18
9,244.64
 
e) Depreciation / Amortisation
2,877.76
2,266.91
9,766.78
8,246.73
10,067.84
8,508.92
 
f) Other Expenditure
9,959.24
7,627.74
35,954.29
24,476.91
36,456.38
25,109.67
g) Total
33089.99
19863.22
99175.73
71551.76
106170.21
78,226.94
5
Profit from Ordinary Activities before & Exceptional Item (3 - 4)
4,862.83
4,486.59
24,840.09
19,896.00
23,929.88
18,190.98
6
 Interest & Finance Charges
2,427.40
2,424.30
8,112.63
9,830.65
8,200.05
9,929.15
7
Profit from Ordinary Activities before & Exceptional Item (5 - 6)
2,435.43
2,062.29
16,727.46
10,065.35
15,729.83
8,261.83
8
Exceptional Item
(777.85)
889.38
7,126.67
993.83
7,126.67
993.83
9

Profit before tax after Exceptional Item
(7 + 8)
1,657.58
2,951.67
23,854.13
11,059.18
22,856.50
9,255.66
10
Tax expenses
     - Current Tax & Deferred Tax
27.77
480.00
5,250.52
1,230.00
5,163.51
1,230.00
     - Fringe Benefit Tax
45.00
45.00
150.00
166.00
159.00
170.78
11
 Net Profit after Tax (9 - 10)
1,584.81
2,426.67
18,453.61
9,663.18
17,533.99
7,854.88
12
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
6,585.08
6,581.63
6,585.08
6,581.63
6,585.08
6,581.63
13
 Reserves excluding Revaluation Reserves
62,224.44
43,542.57
59,912.91
41,927.63
14
 Basic Earnings per Share (EPS) Rs.
2.41
3.69
28.03
14.70
26.63
11.95
15
Diluted Earnings per share (EPS) Rs.
1.62
3.31
18.85
13.23
17.91
10.75
16
Aggregate of Public Shareholding
     - Number of equity shares
55,398,604
50,833,619
55,398,604
50,833,619
     - Percentage of Shareholding
84.13
77.24
84.13
77.24

 
  1. The above financial results were approved by the Board of Directors at its meeting held on Thursday, May 29, 2008.
  2. The Company is operating in single segment (i.e) "Pharmaceuticals".
  3. The Board of Directors has recommended a dividend of 30% (Rs. 3 per share) on the equity share of Rs.10/- each.
  4. In accordance with the revised AS 15, necessary provision has been made for the employee benefits during the period. The increase in liability as at the commencement of the year as per revised AS 15 of Rs.610.50 lakhs has been adjusted against the opening reserves in accordance with the said standard.
  5. Exceptional item represents exchange gain /(loss) on outstanding Foreign Currency Convertible Bonds.
  6. The Board has approved the winding up of its subsidiary, Ogna Farma Distribuicao, Importacao, Exportacao E Assessoria Ltda., Brazil
  7. The Allottment Committee of the Board has allotted shares as follows:
    -12750 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme and 1000 shares at a price of Rs.193.25 per share to employees under ORCHID ESOP 2005 Scheme on January 17,2008.
    -7525 shares (7400 shares at an adjusted price of Rs. 200.44 per share and 125 shares at a price of Rs.193.25 per share) to employees under ORCHID ESOP 1999 Scheme and 1900 equity shares at a price of Rs.193.25 per share under ORCHID ESOP 2005 Scheme, on April 26, 2008.
    -16150 shares at an adjusted price of Rs. 200.44 per share and 25 shares at a revised price of Rs.193.25 per share to employees under ORCHID ESOP 1999 Scheme and 200 shares at a price of Rs.193.25 per share to employees under ORCHID ESOP 2005 Scheme, on May 29, 2008.
  8. The Company received 5 complaints during the quarter ended March 31, 2008 from the shareholders. All the complaints have been resolved and no complaints were pending as on March 31, 2008.
  9. Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : 29-05-2008

For and on behalf of the Board

K. Raghavendra Rao
Managing Director